The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The Functional Impact of Alternative Splicing in Cancer
Open accessAbstract
Alternative splicing changes are frequently observed in cancer and are starting to be recognized as important signatures for tumor progression and therapy. However, their functional impact and relevance to tumorigenesis remain mostly unknown. We carried out a systematic analysis to characterize the potential functional consequences of alternative splicing changes in thousands of tumor samples. This analysis revealed that a subset of alternative splicing changes affect protein domain families that are frequently mutated in tumors and potentially disrupt protein-protein interactions in cancer-related pathways. Moreover, there was a negative correlation between the number of these alternative splicing changes in a sample and the number of somatic mutations in drivers. We propose that a subset of the alternative splicing changes observed in tumors may represent independent oncogenic processes that could be relevant to explain the functional transformations in cancer, and some of them could potentially be considered alternative splicing drivers (AS drivers).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast unfolding of communities in large networks
Blondel, V. D., Guillaume, J.-L., Lambiotte, R., & Lefebvre, E. (2008) · Journal of Statistical Mechanics: Theory and Experiment · doi:10.1088/1742-5468/2008/10/p10008 · Cited by 21,424
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
InterProScan 5: genome-scale protein function classification
Jones, P., Binns, D., Chang, H.-Y., Fraser, M., Li, W., McAnulla, C., McWilliam, H., Maslen, J., Mitchell, A., Nuka, G., et al. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu031 · Cited by 9,301
The Pfam protein families database: towards a more sustainable future
Finn, R. D., Coggill, P., Eberhardt, R. Y., Eddy, S. R., Mistry, J., Mitchell, A. L., Potter, S. C., Punta, M., Qureshi, M., Sangrador-Vegas, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1344 · Cited by 5,975
UpSetR: an R package for the visualization of intersecting sets and their properties
Conway, J. R., Lex, A., & Gehlenborg, N. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx364 · Cited by 3,586
Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq973 · Cited by 3,460
Dosztanyi, Z., Csizmok, V., Tompa, P., & Simon, I. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti541 · Cited by 1,960
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
A Proteome-Scale Map of the Human Interactome Network
Rolland, T., Taşan, M., Charloteaux, B., Pevzner, S. J., Zhong, Q., Sahni, N., Yi, S., Lemmens, I., Fontanillo, C., Mosca, R., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.050 · Cited by 1,360
CORUM: the comprehensive resource of mammalian protein complexes—2009
Ruepp, A., Waegele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., & Mewes, H.-W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp914 · Cited by 1,310
Sotillo, E., Barrett, D. M., Black, K. L., Bagashev, A., Oldridge, D., Wu, G., Sussman, R., Lanauze, C., Ruella, M., Gazzara, M. R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1020 · Cited by 1,254
Context-dependent control of alternative splicing by RNA-binding proteins
Fu, X.-D., & Ares, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3778 · Cited by 1,044
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
The BioGRID interaction database: 2015 update
Chatr-aryamontri, A., Breitkreutz, B.-J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1204 · Cited by 890
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Frampton, G. M., Ali, S. M., Rosenzweig, M., Chmielecki, J., Lu, X., Bauer, T. M., Akimov, M., Bufill, J. A., Lee, C., Jentz, D., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0285 · Cited by 796
Prioritizing candidate disease genes by network-based boosting of genome-wide association data
Lee, I., Blom, U. M., Wang, P. I., Shim, J. E., & Marcotte, E. M. (2011) · Genome Research · doi:10.1101/gr.118992.110 · Cited by 686
ANCHOR: web server for predicting protein binding regions in disordered proteins
Dosztányi, Z., Mészáros, B., & Simon, I. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp518 · Cited by 620
Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing
Yang, X., Coulombe-Huntington, J., Kang, S., Sheynkman, G. M., Hao, T., Richardson, A., Sun, S., Yang, F., Shen, Y. A., Murray, R. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.029 · Cited by 583
Paik, P. K., Drilon, A., Fan, P.-D., Yu, H., Rekhtman, N., Ginsberg, M. S., Borsu, L., Schultz, N., Berger, M. F., Rudin, C. M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1467 · Cited by 575
Therapeutic targeting of splicing in cancer
Lee, S. C.-W., & Abdel-Wahab, O. (2016) · Nature Medicine · doi:10.1038/nm.4165 · Cited by 561
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., & Lehner, B. (2014) · Cell · doi:10.1016/j.cell.2014.01.051 · Cited by 557
Global topological features of cancer proteins in the human interactome
Jonsson, P. F., & Bates, P. A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl390 · Cited by 496
Brock, A., Chang, H., & Huang, S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2556 · Cited by 486
Darman, R. B., Seiler, M., Agrawal, A. A., Lim, K. H., Peng, S., Aird, D., Bailey, S. L., Bhavsar, E. B., Chan, B., Colla, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.053 · Cited by 453
ScanProsite: a reference implementation of a PROSITE scanning tool.
Gattiker, A., Gasteiger, E., & Bairoch, A. (2002) · PubMed · Cited by 433
Tissue-specific alternative splicing remodels protein-protein interaction networks
Ellis, J. D., Barrios-Rodiles, M., Çolak, R., Irimia, M., Kim, T., Calarco, J. A., Wang, X., Pan, Q., O'Hanlon, D., Kim, P. M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.037 · Cited by 431
Buljan, M., Chalancon, G., Eustermann, S., Wagner, G. P., Fuxreiter, M., Bateman, A., & Babu, M. M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.039 · Cited by 396
Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E., Tirode, F., Constantinou, A., Piperno-Neumann, S., Roman-Roman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10615 · Cited by 386
Bechara, E. G., Sebestyén, E., Bernardis, I., Eyras, E., & Valcárcel, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.010 · Cited by 372
Self-citationSRSF1-Regulated Alternative Splicing in Breast Cancer
Anczuków, O., Akerman, M., Cléry, A., Wu, J., Shen, C., Shirole, N. H., Raimer, A., Sun, S., Jensen, M. A., Hua, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.005 · Cited by 367
Widespread intron retention diversifies most cancer transcriptomes
Dvinge, H., & Bradley, R. K. (2015) · Genome Medicine · doi:10.1186/s13073-015-0168-9 · Cited by 344
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Jung, H., Lee, D., Lee, J., Park, D., Kim, Y. J., Park, W.-Y., Hong, D., Park, P. J., & Lee, E. (2015) · Nature Genetics · doi:10.1038/ng.3414 · Cited by 339
3did: a catalog of domain-based interactions of known three-dimensional structure
Mosca, R., Céol, A., Stein, A., Olivella, R., & Aloy, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt887 · Cited by 305
Sebestyén, E., Singh, B., Miñana, B., Pagès, A., Mateo, F., Pujana, M. A., Valcárcel, J., & Eyras, E. (2016) · Genome Research · doi:10.1101/gr.199935.115 · Cited by 276
Self-citationLeveraging transcript quantification for fast computation of alternative splicing profiles
Alamancos, G. P., Pagès, A., Trincado, J. L., Bellora, N., & Eyras, E. (2015) · RNA · doi:10.1261/rna.051557.115 · Cited by 275
Self-citationp53 and its isoforms in cancer
Bourdon, J.-C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603886 · Cited by 245
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato-Otsubo, A., Kohlmann, A., Sanada, M., Grossmann, V., Sundaresan, J., Shiraishi, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7042 · Cited by 240
The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
Zong, F.-Y., Fu, X., Wei, W.-J., Luo, Y.-G., Heiner, M., Cao, L.-J., Fang, Z., Fang, R., Lu, D., Ji, H., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004289 · Cited by 235
Defective control of pre–messenger RNA splicing in human disease
Chabot, B., & Shkreta, L. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 213
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Goldstein, L. D., Lee, J., Gnad, F., Klijn, C., Schaub, A., Reeder, J., Daemen, A., Bakalarski, C. E., Holcomb, T., Shames, D. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.010 · Cited by 200
Sebestyén, E., Zawisza, M., & Eyras, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1392 · Cited by 177
Self-citationStoilov, P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh051 · Cited by 177
Yanagisawa, M., Huveldt, D., Kreinest, P., Lohse, C. M., Cheville, J. C., Parker, A. S., Copland, J. A., & Anastasiadis, P. Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801192200 · Cited by 174
iPfam: a database of protein family and domain interactions found in the Protein Data Bank
Finn, R. D., Miller, B. L., Clements, J., & Bateman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1210 · Cited by 168
Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation
Vorlová, S., Rocco, G., LeFave, C. V., Jodelka, F. M., Hess, K. C., Hastings, M. L., Henke, E., & Cartegni, L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.009 · Cited by 147
DOMINE: a database of protein domain interactions
Raghavachari, B., Tasneem, A., Przytycka, T. M., & Jothi, R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm761 · Cited by 140
dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more
Fang, H., & Gough, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1080 · Cited by 132
Alternative splicing and protein structure evolution
Birzele, F., Csaba, G., & Zimmer, R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1054 · Cited by 119
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
A new reference implementation of the PSICQUIC web service
del‐Toro, N., Dumousseau, M., Orchard, S. E., Jiménez, R. C., Galeota, E., Launay, G., Goll, J. B., Breuer, K., Ono, K., Salwiński, Ł., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt392 · Cited by 115
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis
Zhou, C., Licciulli, S., Avila, J. L., Cho, M., Troutman, S. A., Jiang, P., Kossenkov, A. V., Showe, L. C., Liu, Q., Vachani, A., et al. (2012) · Oncogene · doi:10.1038/onc.2012.99 · Cited by 108
Emerging Roles of Alternative Pre-mRNA Splicing Regulation in Neuronal Development and Function
Norris, A. D., & Calarco, J. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00122 · Cited by 102
Hansen, K. D., Lareau, L. F., Blanchette, M., Green, R. E., Meng, Q., Rehwinkel, J., Gallusser, F., Izaurralde, E., Rio, D. C., Dudoit, S., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000525 · Cited by 89
Lu, Z., Huang, Q., Park, J. W., Shen, S., Lin, L., Tokheim, C. J., Henry, M. D., & Xing, Y. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0366 · Cited by 81
Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations
Yang, F., Petsalaki, E., Rolland, T., HILL, D. E., Vidal, M., & Roth, F. P. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004147 · Cited by 71
Structural genomics analysis of alternative splicing and application to isoform structure modeling
Wang, P., Yan, B., Guo, J., Hicks, C., & Xu, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506770102 · Cited by 67
Pelisch, F., Khauv, D., Risso, G., Stallings‐Mann, M. L., Blaustein, M., Quadrana, L., Radisky, D. C., & Srebrow, A. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24103 · Cited by 65
The prognostic potential of alternative transcript isoforms across human tumors
Trincado, J. L., Sebestyén, E., Pagés, A., & Eyras, E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0339-3 · Cited by 54
Self-citationDifferential connectivity of splicing activators and repressors to the human spliceosome
Akerman, M., Fregoso, O. I., Das, S., Ruse, C. I., Jensen, M. A., Pappin, D., Zhang, M. Q., & Krainer, A. R. (2015) · Genome biology · doi:10.1186/s13059-015-0682-5 · Cited by 50
Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions
Saito, M., Shimada, Y., Shiraishi, K., Sakamoto, H., Tsuta, K., Totsuka, H., Chiku, S., Ichikawa, H., Kato, M., WATANABE, S.-I. I., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3282 · Cited by 43
A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
Claps, G., Chéli, Y., Zhang, T., Scortegagna, M., Lau, E. K., Kim, H., Qi, J., Li, J., James, B. P., Dzung, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.072 · Cited by 19
Cited by
Goodall, G. J., & Wickramasinghe, V. O. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,066
Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution
Ule, J., & Blencowe, B. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.017 · Cited by 780
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Liang, W.-C., Wong, C.-W., Liang, P.-P., Shi, M., Cao, Y., Rao, S.-T., Tsui, S. K.-W., Waye, M. M.-Y., Zhang, Q., Fu, W.-M., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1685-4 · Cited by 493
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
Metadata
- Authors
- Climente-González, H., Porta-Pardo, E., Godzik, A., & Eyras, E.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 20
- Issue
- 9
- Pages
- 2215-2226
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2750771238
- Cited by
- 552
- References
- 63
- FWCI
- 20.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.